M ultiple myeloma (MM) is characterized by the uncontrolled proliferation of plasma cells and the accumulation of their secreted monoclonal free Ig L chain (FLC) (1) . A complication frequently observed in MM patients is the deposition of FLC aggregates in organs. These can be as ordered amyloid fibrils (referred to as LC amyloidosis), or amorphous deposits (LC deposition disease). The formation of LC aggregates is thought to be due to partial unfolding of FLCs into an intermediate structure and subsequent self-association of adjacent b strands (2) (3) (4) (5) . Protein denaturation methods, such as heat and high-ionic strength buffers, can promote FLC aggregation in vitro (3, 6) . Very little is known about the process in vivo, although a recent study suggested that FLC aggregation can be induced by interactions with biological membranes (7) .
There are two isotypes of FLCs, designated k or l, with the former accounting for 61% of MM cases (8) . The mAb K-1-21 recognizes a conformational epitope on free k LCs (FkLCs) (9) . Interestingly, it also binds a cell surface-associated form of FkLC, termed k myeloma Ag (KMA), expressed on plasma cells from patients with kLC isotype MM and on malignant cells in other B cell lineage diseases such as Waldenström's macroglobulinemia and non-Hodgkin's lymphoma (10) (11) (12) . The expression of KMA on a range of B cell malignancies has led to the development of a human chimeric IgG1 version of K-1-21, designated MDX1097, which has recently undergone a phase I clinical trial for the treatment of kLC isotype MM (13) .
The mechanism by which FkLCs associate with the cell membrane to form KMA is not immediately clear given the absence of recognizable structural motifs through which they may intercalate in the lipid bilayer. Early immunoprecipitation attempts on KMAexpressing cells by K-1-21 revealed that the Ag is primarily composed of FkLCs. In the same study, actin was identified as a protein that coprecipitated with KMA and hence may have played a role in the association of FkLCs with the cell membrane (14) . However, subsequent immunoprecipitation attempts have failed to identify actin or any proteins other than FkLCs in the KMA complex (Supplemental Fig. 1 ). Given the potential of KMA as a therapeutic target, the mode by which FkLCs could be bound to the plasma membrane remains of considerable interest.
In this study, we show that KMA consists of only FkLCs in direct association with the plasma membrane of FkLC-secreting cells. Molecular characterization of KMA reveals that FkLCs are in an aggregated form, which suggests that this is a requirement for stable association with membranes. Furthermore, binding studies using large unilamellar vesicles (LUVs) show that FkLCs associate with membranes composed of saturated phosphocholine (PC) lipids such as sphingomyelin. This was confirmed in FkLC-secreting cell lines in which blockage of the breakdown of sphingomyelin resulted in increased levels of sphingomyelin and concomitant KMA expression. Collectively, the results support a model for KMA expression by B cells where FkLCs interact with sphingomyelin and undergo aggregation leading to stable association with membranes in secretory vesicles destined for exocytosis. It follows that fusion of the vesicle with the plasma membrane exposes membrane-associated FkLCs on the extracellular face of the cell as KMA. Although a large number of protein aggregates have been shown to bind membranes (reviewed in Ref. 15) , this is only the second time protein aggregates have been observed on the surface of cells secreting a protein in its native form (16) . Based on these findings, we postulate that many other aggregation-prone proteins may associate with plasma membranes of secretory cells by similar mechanisms. FkLCs were purified from the urine of MM patients by ammonium sulfate precipitation as described previously (9) . Lysenin and BSA were obtained from Sigma-Aldrich.
Materials and Methods

Cell lines and general reagents
Flow cytometry
Cells were stained with MDX1097-allophycocyanin (or human IgGallophycocyanin) for detection of KMA. For sphingomyelin detection, cells were incubated with 5 mg/ml biotinylated lysenin for 30 min on ice followed by streptavidin-allophycocyanin. Fluorescence was recorded on a FACSCalibur flow cytometer (BD Biosciences, North Ryde, New South Wales, Australia) and then analyzed by FCS Express V3 software (De Novo Software, Los Angeles, CA).
In the experiments indicated, cells were incubated with 5 mM GW4869 (Sigma-Aldrich) under normal tissue culture conditions. After 48 h, cells were harvested for downstream flow cytometric analysis.
Measurement of FkLC secretion
ARH-77_100, ARH-77_neg, NCI-H929, and JJN-3 cells were set up at 2 3 10 5 cells/ml and incubated at cell culture conditions for 96 h. Supernatants were kept then assessed for FkLC secretion by K-1-21 ELISA. Briefly, ELISA plates were precoated with K-1-21 and then samples were added to each well in triplicate. Plates were incubated for 90 min at 37˚C. Bound FkLCs were detected with anti-kLC alkaline phosphatase (AP) (Sigma-Aldrich).
Sodium carbonate membrane extraction
Cellular membranes were prepared from ARH-77_100 or JJN-3 cells according to previously described methods (17) . The following membrane extraction method is adapted from Fujiki et al. (18) . Membranes were treated with 0.1 M Na 2 CO 3 at pH 11 for 30 min on ice, followed by centrifugation at 20,000 3 g for 30 min. Membranes were washed in PBS/ sodium azide twice and then pelleted at 20,000 3 g. Membranes were resuspended in 1% (v/v) Triton X-100 (TX100) PBS/sodium azide and centrifuged to remove cell debris.
Samples were separated by SDS-PAGE under nonreducing conditions followed by transfer to nitrocellulose membranes and Western blotting with rabbit anti-actin (Sigma-Aldrich) and rabbit anti-calnexin (Sigma-Aldrich) with the secondary Ab being anti-rabbit IgG peroxidase (Sigma-Aldrich). The kLC was detected by a goat anti-human kLC AP-conjugated IgG (Sigma-Aldrich).
Two-dimensional blue native and SDS-PAGE
Blue native (BN)-PAGE was performed using 4-16% native PAGE precast gels by the procedure described by the manufacturer for BN-PAGE analysis (Invitrogen). When performing second dimension SDS-PAGE on BN-PAGE-fractionated samples, the lane of interest was equilibrated in SDS-loading buffer then separated in a 4-12% Bis-Tris gel (Invitrogen) followed by Western blotting with anti-kLC AP.
Dynamic light scattering measurements of FkLC
Dynamic light scattering (DLS) measurements were made on a Zetasizer Nano ZS instrument (Malvern, U.K.) fitted with a 633-nm helium-neon laser. To assess the point at which FkLCs began to form aggregates, a temperature analysis was performed whereby readings were made from 25˚C to 65˚C. Additionally, readings were made at 37˚C and 50˚C as well as at 37˚C after 15 min of incubation at 50˚C. Data were analyzed by Dispersion Technology Software from Malvern Instruments (Sutherland, New South Wales, Australia). The hydrodynamic diameter (D H ) was determined by the cumulants method (19) . Percentage intensity versus particle size was determined by nonlinear least squares analysis of the DLS correlation functions.
Preparation of LUVs
LUVs were made according to the method described by Hope et al. (20) . Phospholipids (20 mg) were dissolved in 2 ml of chloroform. Additionally, 4 ml of the pink lipophilic tracer dye 1,19-dioctadecyl-3,3,39,39-tetramethylindocarbocyanine perchlorate (Invitrogen) was added so that LUVs could be visualized later. The lipid mixture was placed into a round-bottom glass flask, and chloroform was removed by rotary evaporation and then lyophilized overnight. Lipids were hydrated in 2 ml of PBS with 10% sucrose. The mixture was placed onto a mini-extruder (Avanti Polar Lipids, Alabaster, AL) and passed through a 100-nm polycarbonate filter to generate LUVs.
FkLC-LUV sucrose flotation assay
LUVs (250 ml) were incubated with 1 mg/ml FkLCs for the times and temperatures indicated. The LUV-FkLC mixture was transferred to a centrifuge tube and overlaid with a discontinuous sucrose gradient in PBS/ sodium azide containing 3 ml of 60%, 4 ml of 40%, 3 ml of 20%, and 2 ml of 5% sucrose. The sample was then centrifuged at 100,000 3 g for 20 h. Samples (1 ml) were taken from the top, with fraction No. 3 representing the LUV fraction. Fraction No. 10 consisted of the bottom 3 ml.
For densitometry, each fraction was separated by reducing SDS-PAGE and then developed by silver stain. The gels were photographed with a ChemiDoc imager (Bio-Rad Laboratories, Gladesville, New South Wales, Australia), and the average density of bands was assessed by Quantity One 1-D analysis software (Bio-Rad Laboratories). The density of each lane was expressed relative to the density of the bottom fraction.
Surface plasmon resonance (SPR) was performed on a Biacore 2000 (GE Healthcare, Rydalmere, New South Wales, Australia). Fraction No. 3 from each sample and FkLC-positive controls were injected at a flow rate of 20 ml/min for 5 min over an MDX1097-coated CM5 sensor chip (GE Healthcare). Arbitrary response units (RUs) were measured 2.5 min after the injection.
Phospholipid ELISA
PolySorp 96-well ELISA plates (Nunc, Roskilde, Denmark) were dried under nitrogen gas with 100 ml of 100 mg/ml lipids dissolved in ethanol. Wells were washed with 200 ml of 0.3% BSA-PBS and then blocked with 100 ml of 1% BSA-PBS for 1 h at 37˚C. Aliquots (100 ml) of either 200 mg/ml biotinylated FkLCs or human k Fab (purchased from Bethyl Laboratories, Montgomery, TX) were added to the wells, performing serial dilutions in 0.3% BSA-PBS. Plates were incubated for 90 min at 37˚C, and then bound protein was detected by ExtrAvidin AP. Phospholipids were purchased from Avanti Polar Lipids.
Sphingomyelin assay
Determination of cellular sphingomyelin content was performed as previously described by Hojjati and Jiang (21) . Additionally, a BCA protein assay was performed on the samples according to the manufacturer's recommendations (Thermo Scientific, Rockford, IL). Total cellular sphingomyelin was calculated with reference to the standard curve and was expressed as either per 10 7 cells or per milligram of protein.
Transfection of kLCs into HEK-293 cells
Expression plasmids (pT-Rex) encoding full-length JJN-3 kLCs and constant domain only kLCs (starting at Val
104
) were transfected into HEK-293 cells by the FreeStyle Max expression system (Invitrogen). Three days after transfection, cells were harvested and analyzed for KMA expression by flow cytometry. Supernatants were also assessed for FkLC secretion levels by MDX1097 SPR.
Molecular modeling of PC-FkLC complexes
All modeling programs used in this study are from Schrödinger (New York, NY). Coordinates for PC were extracted from the Protein Data Bank (PDB) entry 2MCP and parameterized using the OPLS force field using MacroModel version 9.7. PC was docked in its zwitterionic form. The crystal structure of DEL (PDB code 1B6D), a noncovalent human kLC dimer (22) , was prepared using the Protein Preparation Wizard in Maestro, version 9.0. Molecular docking was performed using Extra Precision (XP) mode in Glide, version 5.5 (Schrödinger). The scoring grids were set up within a cubic box (30 Å sides) centered at the centroid of the following residues: Gln 
Results
Expression of KMA is not directly related to the level of FkLC secretion in MM cell lines
Four kLC isotype MM-derived cell lines, JJN-3, NCI-H929, ARH-77_100, and ARH-77_neg, were assessed for KMA expression by immunostaining with MDX1097 and analysis by flow cytometry. KMA was detected on JJN-3 and ARH-77_100 cells but was not expressed on NCI-H929 and ARH-77_neg cells (Fig.  1A ). To verify that these cell lines were secreting FkLCs, day 4 cell culture supernatants were assessed for the presence of FkLCs by ELISA (Fig. 1B) . To allow comparisons between cell lines, the amount of secreted FkLCs was normalized to final cell density. As expected, all cell lines secreted FkLCs, although the amounts varied widely between cell lines. Interestingly, the highest FkLC secretor was the non-KMA-expressing cell line NCI-H929 (5.71 6 0.33 pg/cell). JJN-3 cells secreted intermediate levels of FkLCs and strongly expressed KMA (1.63 6 0.05 pg/cell). Furthermore, whereas ARH-77_100 (0.29 6 0.02 pg/cell) and ARH-77_neg (0.29 6 0.03 pg/cell) secreted equivalent, yet small amounts of FkLCs, only ARH-77_100 expressed KMA (Fig. 1 ). This infers that there are additional factors involved in KMA expression by plasma cells other than the synthesis of FkLCs alone.
KMA consists of a high-molecular mass complex of FkLCs associated with the membrane via electrostatic and hydrophobic interactions
The molecular nature of KMA was investigated by analysis of plasma membrane proteins using BN-PAGE. Plasma membranes from KMA-expressing ARH-77_100 cells were fractionated by BN-PAGE followed by Western blotting for kLCs. The kLCs in the ARH-77_100 membrane fraction was present in a complex of ∼480 kDa. In contrast, when soluble FkLCs were subjected to electrophoresis under the same conditions, they were found to migrate with a relative molecular mass of ∼66 kDa, which is the approximate size of a FkLC dimer ( Fig. 2A) . This finding suggests that KMA consists of FkLCs that reside in a membrane-associated high-molecular mass complex. To exclude the possibility that this complex may contain H chain (HC)-associated kLCs in the form of intact Ig, ARH-77_100 membrane proteins fractionated by BN-PAGE in the first dimension were then subjected to SDS-PAGE under nonreducing conditions in the second dimension. kLCs, detected by Western blot, migrated at an approximate molecular mass of 28 kDa, thus confirming the presence of FkLCs in the 480 kDa complex (Fig. 2B) . Furthermore, the failure to detect components in the molecular mass range .98 kDa in the SDS-PAGE dimension confirmed that HC-associated kLCs in the form of intact Ig was not present in the 480 kDa complex. In contrast to immunoprecipitation experiments where covalent FkLC dimers are often observed (Supplemental Fig. 1 ), covalent dimers were not present in the BN-PAGE/SDS-PAGE fractionated material. We have noted that when membranes are solubilized in the presence of an alkylating agent, covalent dimers are not found (Supplemental Fig. 2 ), leading to the conclusion that the formation of covalent dimers is a postsolubilization oxidation effect and does not occur under the conditions used for BN-PAGE.
Despite one early report that identified actin as a KMA-associated protein in immunoprecipitates (14), we have consistently failed to identify any non-FkLC components in immunoprecipitates of KMA (Supplemental Fig. 1 ). This suggests that FkLC associates directly with the plasma membrane to form KMA rather than being bound to a membrane-associated receptor. A simple method to determine the mode of interaction of a protein with membranes is to incubate them with high-ionic strength, high-pH Na 2 CO 3 buffer. If the membrane protein is associated primarily through electrostatic forces, which are typical of both receptor-ligand interactions and peripheral membrane proteins, then the complexes are easily disrupted and dissociated from the membrane. If, however, the protein is integral and primarily associates with the membrane through hydrophobic interactions with the acyl core of the lipid bilayer, then it will be highly resilient to such treatments (18, 23) .
Purified membranes from ARH-77_100 and JJN-3 were incubated with 0.1 M Na 2 CO 3 (pH 11) buffer for 30 min. After incubation, membranes were pelleted by centrifugation and supernatant was collected for analysis of proteins that were released following disruption of electrostatic interactions. Treated membranes were then washed three times in PBS and solubilized in FIGURE 1. KMA expression does not correlate with the level of FkLC secretion. A, FACS analysis of MM-derived kLC cell lines stained with MDX1097-allophycocyanin (black histograms) or human IgGallophycocyanin control (gray histograms). B, Total FkLC secretion measured by K-1-21-specific ELISA and expressed relative to final cell density. Data presented are means 6 SE from three measurements (except NCI-H929, which is from two measurements). 1% TX100. This was followed by one round of centrifugation to remove TX100-insoluble proteins. The Na 2 CO 3 and TX100-soluble fractions were fractionated by SDS-PAGE and assessed by Western blot probing for kLCs. As controls, calnexin and actin, being integral and peripheral membrane proteins, respectively (24, 25) , were detected by Western blot.
As expected, the peripheral membrane protein actin was only recovered in the Na 2 CO 3 aqueous fraction. Calnexin, being a typical integral membrane protein, was found predominantly in the TX100 detergent fraction, with a small amount recovered in the Na 2 CO 3 aqueous fraction (Fig. 2C) . Although it was surprising to see some calnexin recovered in the Na 2 CO 3 fraction, this result is in line with a previous report that showed that calnexin can be released from membranes by Na 2 CO 3 extraction (26) .
Interestingly, FkLC was recovered in both fractions. For ARH-77_100 membranes, FkLC was equally distributed across the aqueous and detergent fractions, whereas for JJN-3 membranes, FkLC was found predominantly in the Na 2 CO 3 aqueous fraction, with ∼25% being present in the TX100 fraction (Fig. 2C) . Based on these results, membrane-associated FkLCs appear to be more resistant to Na 2 CO 3 treatment than to actin, but less so than to calnexin. We interpret these findings as indicating that there are both electrostatic and hydrophobic interactions involved in the association of FkLCs with the cell membrane. Based on these results, KMA cannot be clearly designated as either a peripheral or an integral membrane protein. Interestingly, extraction of membranes with TX114 or urea show that FkLC behaves more like calnexin than actin in its ability to associate with membranes (Supplemental Fig. 3) , which reinforces the conclusion that KMA cannot be classed as a typical peripheral membrane protein where electrostatic forces are the dominant mode of attachment.
Aggregated FkLCs bind membranes
The finding that KMA consists of a high-molecular mass complex containing FkLCs that are directly associated with the plasma membrane raised the possibility that the FkLCs in KMA are in an aggregated form.
To assess whether FkLC aggregation is required for membrane association, we initially determined the temperature at which FkLCs assembled into aggregates by DLS measurements. At temperatures .49˚C, the D H of FkLCs was seen to increase markedly (Fig. 3A) , and this was interpreted as the temperature at which FkLCs began to assemble into aggregates. Additionally, we compared the size distributions of FkLCs at 37˚C and after 15 min of incubation at 50˚C. There was a uniform increase in size distribution from a peak of 8 nm at 37˚C to 21 nm at 50˚C, indicating that aggregates had formed. After cooling samples back to 37˚C, the FkLC aggregates remained at the same size, indicating that heat-induced aggregation is irreversible (Fig. 3B) . These stable and soluble FkLC aggregates (solutions remained transparent) approximate the sizes of polymeric IgM, which have D H of 34-37 nm when measured by DLS (27) .
To determine whether the aggregation of FkLCs may play a role in the binding of the protein to membranes, studies were undertaken using LUVs as model membranes. LUVs were incubated with FkLCs for 15 min at either 37˚C or 50˚C to induce protein aggregation. The amount of FkLCs bound to LUVs was then assessed by isolating LUV-bound FkLCs by sucrose density gradient centrifugation. Fractions from the density gradient were subjected to SDS-PAGE followed by silver staining to reveal proteins. Densitometry of the silver-stained SDS-PAGE gels revealed that there was significant binding of FkLCs to LUVs when heated to 50˚C as shown by a sharp peak in protein concentration at fraction No. 3, the fraction in which LUVs were found after centrifugation. However, when FkLCs were incubated with LUVs at 37˚C, the protein was broadly distributed across fraction Nos. 3-10, whereas without LUVs the FkLC was only found in fraction Nos. 6-10, with the majority in Nos. 9 and 10 ( Fig. 3D) . Furthermore, these results were confirmed by SPR binding analysis of the density gradient fractions using an MDX1097-coated sensor chip that revealed the presence of FkLCs in fraction No. 3 for the sample heated to 50˚C (804.2 6 18.2 RUs) when compared with the sample incubated at 37˚C (169.8 6 5.8 RUs) and the no LUV control sample (no detectable binding) (Fig. 3E) . Because heating induces aggregation and enhances FkLC membrane association, these data clearly support the hypothesis that KMA consists of membrane-associated aggregated FkLCs.
FkLCs associate with saturated PC lipids
Although the previous findings suggest that FkLCs require aggregation to associate with membranes as KMA, they do not explain why some, but not all, FkLC-secreting B cells express KMA. There is mounting evidence that phospholipids can promote aggregation of proteins and that the aggregation is determined mainly by the class of phospholipid species (reviewed in Ref. 15) . Therefore, FkLCs may show a tendency to associate with a particular class of membrane lipid, suggesting that certain lipids could be more abundant in KMA-positive cells compared with KMA-negative cells.
Common species of phospholipids, namely sphingomyelin, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC), 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPC), 1-palmitoyl-2-FIGURE 2. Membrane-associated FkLC, as KMA, resides in a large molecular complex and is directly associated with the cell membrane. A, ARH-77_100 membrane proteins and soluble FkLCs were separated by BN-PAGE and then Western blotted to detect kLCs. B, ARH-77_100 membrane proteins were separated by BN-PAGE then subjected to nonreducing SDS-PAGE in the second dimension followed by Western blotting to detect kLCs. C, Cell membranes from KMA expressing cell lines were solubilized with either Na 2 CO 3 or TX100 and the extracts subjected to SDS-PAGE. Western blots were probed with Abs specific for kLCs, calnexin, or actin.
oleoyl-sn-glycero-3-phosphatidylethanolamine (POPE), and 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphatidylserine (POPS), were coated onto hydrophobic 96-well plates. These were dried under a stream of nitrogen, resulting in lipid monolayers. Plates were blocked with BSA and incubated with serial dilutions of biotinylated FkLCs or biotinylated Fab as a control. Bound protein was detected with streptavidin-AP conjugate. The highest level of binding by FkLCs was to sphingomyelin, followed by POPC, and the binding reached saturation at 100 mg/ml on both phospholipid monolayers. There was weaker binding to DOPC and POPS, while POPE showed no reactivity with FkLCs (Fig. 4A) . Biotinylated Fab showed no binding at any of the concentrations tested (Fig. 4B) .
Sphingomyelin, POPC, and DOPC represent disaturated, monosaturated, and unsaturated PC lipids, respectively. However, only sphingomyelin and POPC show association with FkLCs. This suggests a requirement for both a PC head group and saturated acyl tails to bind FkLCs. To confirm that FkLCs bind preferentially to saturated PC-type lipids, an LUV sucrose density gradient flotation assay was performed comparing the ability of FkLCs to associate with PC lipid species that have different levels of saturation in their acyl tails. Briefly, LUVs were prepared in a 3:1:1 molar ratio of a PC lipid, POPS, and POPE in 10% sucrose PBS and incubated with FkLCs at 37˚C for 2 h to approximate physiological conditions. After incubation, the LUV/FkLC mixture was separated by centrifugation over a sucrose gradient, with the LUV fraction recovered at the 5-20% sucrose density interphase.
LUV fractions were subjected to analysis by SPR to detect the presence of membrane-bound FkLCs by reactivity with MDX1097 (Fig. 4C) . Both sphingomyelin-and POPC-based LUVs bound FkLCs, as indicated by reactivity with the MDX1097-coated sensor chip (306 6 0.3 and 363 6 0.3 RUs, respectively). In contrast, LUVs consisting of the unsaturated PC species, DOPC, showed no binding above the FkLC alone negative control fraction (109 6 2.1 and 125 6 7.3 RUs, respectively; Fig. 4C ). These results are consistent with the previous data and confirm a requirement for saturated PC lipid species, such as sphingomyelin, for the association of FkLCs with membranes. Moreover, based on MDX1097 binding, LUV-associated FkLCs were recognizable as KMA.
KMA expression is sphingomyelin dependent
Because the previous experiment indicated a role for saturated PC lipids, such as sphingomyelin, in the binding of FkLCs to cell membranes, we examined the sphingomyelin levels in KMApositive and -negative cell lines. Total sphingomyelin was measured according to the methods set out by Hojjati and Jiang (21) and was expressed either as the amount per 10 7 cells or per milligram of protein. Cell lines were separated into high and low FkLC secretors as previously determined (Fig. 1B) . Within each of these groups there was one KMA-positive cell line and one KMAnegative cell line. Sphingomyelin levels were significantly higher in the KMA-positive cells, irrespective of the FkLC secretion status. Thus, for the high FkLC secretors, the KMA-positive cell line JJN-3 expressed ∼2-fold more sphingomyelin than its KMAnegative counterpart, NCI-H929. For the low FkLC secretors, ARH-77_100 KMA-positive cells expressed 25-50% more sphingomyelin than did ARH-77_neg cells (Fig. 5A, 5B) . These results show a clear positive correlation with respect to KMA expression and sphingomyelin levels.
Sphingomyelin levels were also assessed by the binding of lysenin, a protein with high specificity for sphingomyelin, to cell membranes (28, 29) . KMA-positive (ARH-77_100 and JJN-3 cells) and -negative cell lines (ARH-77_neg and NCI-H929 cells) were incubated with biotinylated lysenin followed by staining with streptavidin-allophycocyanin. Cells were then analyzed by flow cytometry to measure the level of lysenin binding. Based on geometric mean fluorescence intensity, both of the KMApositive cell lines expressed higher levels of plasma membrane sphingomyelin compared with the KMA-negative cells (Fig. 5C,  5D ). Given the trend of increased plasma membrane sphingomyelin and KMA expression, these results further support the hypothesis that KMA is associated with sphingomyelin on the plasma membrane.
Neutral sphingomyelinase is an enzyme responsible for the breakdown of sphingomyelin into ceramide and PC (30) . Disruption of this pathway by a highly specific small molecule neutral sphingomyelinase inhibitor (GW4869) results in the accumulation of sphingomyelin in cellular membranes (31) . It was reasoned that if sphingomyelin was directly associated with KMA, then upregulation of the phospholipid by GW4869 would increase KMA expression in FkLC-secreting cells.
GW4869 treatment resulted in upregulation of sphingomyelin levels in all cell lines except ARH-77_100, and upregulation of sphingomyelin was highly correlated with KMA expression. KMA expression was increased in the KMA-positive cell line, JJN3, whereas the two KMA-negative cell lines, NCI-H929 and ARH77_neg, were induced to express the Ag after treatment with GW4869. ARH-77_100 cells failed to upregulate plasma membrane sphingomyelin levels in response to GW4869, and, consistent with this, they did not express higher levels of KMA (Fig. 5D) . The failure of ARH-77_100 to respond to GW4869 treatment may indicate that membrane sphingomyelin levels are saturated in these cells. Analysis of cell supernatants by SPR showed that FkLC secretion levels from all cell lines were actually lower after GW4869 treatment (data not shown). Because KMA upregulation could not be accounted for by an increase in FkLC secretion, these results, together with the lipid binding studies, clearly demonstrate that sphingomyelin is an important membrane component for the expression of KMA by FkLC-secreting cells.
The V domain is required for KMA expression
To gain further insight into the mechanism by which FkLCs bind to the plasma membrane, HEK-293 cells were transfected with genes encoding either the full-length JJN-3 kLC or a truncated form of JJN-3 kLC, encoding only the C domain. The latter construct retains the epitope bound by K-1-21 and MDX1097 (Supplemental Table 1 ) (9). Cells were harvested 3 d posttransfection and analyzed for KMA expression by flow cytometry. KMA expression was observed on the full-length kLC transfectants (8.7% KMA-positive cells) but was absent on the C domain only transfectants (Fig. 5E) . Importantly, both tranfectants expressed comparable amounts of secreted product (1.0:0.9 molar ratio of normal kLCs/C domain only kLCs; Supplemental Table 1 ). These results clearly indicate that the V domain of FkLCs is necessary for stable association of the protein with the plasma membrane as KMA.
Identification of a putative binding site for PC in kLC V domains
Our experimental findings demonstrate that FkLC interacts with PC-saturated lipid species (Fig. 4) , and that the interaction is dependent on the V domain (Fig. 5E) . Thus, molecular docking was used to examine possible binding modes of the PC lipid head group into a conserved pocket identified in the V domains of kLCs (Fig. 6) . Docking of the PC ligand demonstrates that it is primarily anchored to the binding site via interaction of the N + (CH 3 ) 3 group (i.e., the charged portion of the choline moiety) with Asp 82 and hydrogen bonding of the phosphate group with Lys 39 (Fig. 6A) . Close contacts also occur between the PC ligand and hydrophobic residues such as Phe 62 . Although interactions are very similar After incubation with FkLCs, LUVs were fractionated by sucrose density centrifugation and assessed for their ability to bind to an MDX1097-coated sensor chip. A BSA-coated chip was used as a control. Soluble FkLC standards at 10 and 2 mg/ml were used as positive controls. Data presented are means 6 SE from two measurements.
for the two binding sites of the kLC dimer, due to subtle conformational differences in the protein, the binding site on chain B provides an additional carboxylate group (Glu 81 ) for interaction with the choline moiety (Fig. 6A) . A surface view shows that the putative PC binding cavity is of a suitable size for accommodating the ligand with the choline moiety binding by an end-on insertion mechanism (Fig. 6B) , which is a typical binding mode for haptens and some small carbohydrates and peptides (32, 33) . Importantly, the phosphate group is bound near the entrance to the cavity in a position suitable for extension with the lipid tail, that is, pieces representative of membrane lipids. Views of the two LC monomers show that the proposed binding of PC in the V domain is unimpeded by the conformation of the LC, being either extended or bent with respect to the positions of the V and C domains (Fig.  6C) . Additionally, the binding of two PC ligands could easily occur in a FkLC dimer, as illustrated with the docked model shown in Fig. 6D (model derived from PDB structure 1B6D).
Discussion
Membrane extraction studies reveal that FkLCs are in direct association with the plasma membrane as KMA. This was confirmed in experiments that showed that FkLCs can bind directly to membranes composed of saturated PC lipids. Furthermore, heatinduced aggregation substantially increases binding of FkLCs to LUVs, suggesting that self-association is required for stable interaction with membranes. This was supported by BN-PAGE anal- ysis of membrane proteins from ARH-77_100 cells, which showed that KMA resides in a large protein complex of ∼480 kDa. Separation of this complex by SDS-PAGE under nonreducing conditions revealed the presence of FkLC monomers, indicating that KMA is composed of FkLC aggregates.
kLCs can also be found in association with HCs as part of the BCR on MM cells; however, KMA is clearly distinguishable from this complex. For example, K-1-21 and its human chimeric equivalent, MDX-1097, exhibit well-defined specificity for FkLCs and show no reactivity with HC-associated kLCs (10). When these mAbs are used to immunoprecipitate KMA from myeloma cell membranes, only FkLC is eluted, which indicates that KMA is not composed of HC-associated kLCs (Supplemental Fig. 1) (14) . Furthermore, when solubilized plasma membranes from KMAexpressing cells are fractionated by SDS-PAGE under nonreducing conditions and probed with anti-kLCs, FkLCs are detected, whereas HC-associated kLCs in the form of Ig is not observed (Supplemental Fig. 2 ), indicating that Ig is either not present or is present at levels below the detection limit of the assay.
As FkLC is a secreted molecule, membrane association may occur on membranes of vesicles destined for exocytosis. This is supported by the finding that brefeldin A, which blocks the normal secretion route in eukaryotic cells, inhibits KMA expression on ARH-77_100 cells (see Supplemental Fig. 4 ). Our studies showed that FkLCs interact with mono-and disaturated PC lipid species, such as sphingomyelin and POPC, and that KMA expression can be induced on KMA-negative cell lines by increasing sphingomyelin levels. As such, these findings suggest that in high enough concentrations of these lipids, FkLCs bind to membranes of vescicles that are destined for secretion and become exposed on the extracellular face as KMA during exocytosis. A schematic for KMA expression that accounts for our experimental findings is presented in Fig. 7 .
An interesting aspect of the membrane extraction studies is that membrane-associated FkLCs, as KMA, share properties of both integral and peripheral-associated membrane proteins. In particular, KMA was found to be associated with the membrane via a combination of hydrophobic and electrostatic forces. Given the evidence that FkLCs are aggregated on the membrane, the electrostatic component observed in the membrane extraction study may represent the interaction of PC-charged head groups with individual FkLC molecules. The hydrophobic component, which is thought to govern aggregation processes (34, 35) , may indicate interactions between adjacent FkLC molecules. In support of this model, the l isotype of LCs was previously shown to interact directly with artificial membranes composed of POPC. This was a two-step process with an initial electrostatic interaction followed by a higher energy driven hydrophobic effect. The authors described this second event as a reorientation of Ig domains (36) . In light of our findings with FkLCs, the binding of FkLCs could be interpreted as a self-association (aggregation) event after an initial contact with the membrane. Furthermore, this finding suggests that membrane association is a property of both LC isotypes. Subsequently, we have discovered the lLC equivalent to KMA, termed l myeloma Ag (LMA), which is found on the surface of l isotype MM cells (D.R. Jones, A.T. Hutchinson, P. Asvadi, R.D. Dunn, R.L. Raison, manuscript in preparation).
We also identified a highly conserved pocket in V domains of LCs that exhibited surface-exposed positive and negative charges that may interact with a zwitterionic PC molecule. Molecular docking studies showed that PC could be accommodated in this region via electrostatic and van der Waals forces between Asp 82 and positively charged choline, hydrogen bonding of Lys 39 with the phosphate group, and a hydrophobic interaction between choline and Phe 62 . An additional carboxylate group (Glu 81 ) can interact with the choline moiety with only small adjustments in the putative PC binding cavity. Importantly, PC is orientated so that if acyl groups are present, as in a saturated lipid, then these could extend outward from the binding pocket as part of a membrane. Because this is a model, the interaction of PC with this region would need to be validated by experimental findings. Note, however, that in crystal structures of the lLC dimer, Mcg, heavy atom compounds bind (37) , and zinc ions are likely to be found in this pocket (38) , which supports its putative role in binding ligands such as PC.
Studies have suggested that membrane association is a general property shared by many aggregation-prone proteins (15, 39) . In fact, it has been argued that amyloid formation in vivo actually arises due to specific interactions of proteins with lipid bilayers. One general model of amyloid deposition proposed that fibril formation arises via several distinct steps: 1) the initial protein-lipid interaction, which is thought to be electrostatic; 2) a conformational change in the protein that allows for self-association; 3) aggregation on the membrane surface; and 4) fibril formation as individual molecules grow outward from the membrane-associated aggregate (15) . In relationship to our studies, membrane association may proceed in a similar manner whereby FkLCs undergo a conformational change after interaction with saturated PC lipids, allowing them to self-associate and stabilize on the membrane surface as KMA. It also follows that the process of aggregation in vivo by FkLCs, such as in LC amyloidosis and LC deposition disease, may be induced by saturated PC lipids present on membrane surfaces. Interestingly, a recent study by Farrugia et al. (40) showed that Fab molecules aggregate in the presence of zinc ions. Because the proposed PC binding site is structurally homologous to the zinc binding site in lLC (as previously discussed), it is possible that these ligands may induce aggregation by similar mechanisms.
FkLC is not unique in that a-synuclein, which is the primary structural component of Lewy body fibrils, has also been found to exist as a plasma membrane-associated aggregate on the neuronal cells that secrete the protein in its native form (16) . This raises the question as to whether other aggregation-prone proteins can associate with the extracellular plasma membrane face in a similar fashion. In one study, insulin has been shown to directly associate with the plasma membrane of rat pancreatic cells, and this was dependent on the rates of secretion (41) . With similarities to FkLC and a-synuclein, insulin can also undergo self-aggregation in the form of an amyloid (42, 43) . As such, it would be interesting to ascertain whether insulin requires aggregation to associate with plasma membranes on islet cells.
In summary, we have described the characteristics required for a FkLC-secreting plasma cell to express KMA. We found that FkLC directly associates with saturated PC lipid species such as sphingomyelin. Moreover, increasing the levels of sphingomyelin in cell membranes was able to induce KMA expression in otherwise non-KMA-expressing cell lines. Although we cannot exclude a role for other PC-containing lipids, such as POPC, our data support a dominant role for sphingomyelin in the membrane association of FkLCs in the form of KMA. As membrane-associated FkLCs exist as large-molecular mass species, we propose that the interaction with these lipids causes FkLCs to self-associate into aggregates that are stabilized by multivalent binding on the membrane. It follows that exocytosis of the secretory vesicle allows for fusion with the plasma membrane exposing membrane-associated FkLCs on the extracellular face as KMA. It is well known that protein aggregates can bind membranes (15, 39) . However, this is only the second example of protein aggregates being observed on the extracellular membrane surface of cells that are secreting the protein in its native form. Future work could explore whether other cells that secrete aggregation-prone proteins also express a plasma membrane-associated form of the molecule. This could lead to the development of compounds that specifically target the plasma membrane form of the protein and thereby help eliminate the cells responsible for the production of pathogenic protein aggregates. 
